Agencia Española de Medicamentos y Productos Sanitarios (AEMPS)
CIMA — Centro de Información de Medicamentos · Spain
- Updated
- Not provided for this source record
- Synchronized
- Oct 2, 2026
Medicine · Spain
CANDESARTAN/HIDROCLOROTIAZIDA KRKA 32 MG/25 MG COMPRIMIDOS EFG
Tablet
Home Med Cabinet
Updated · Agencia Española de Medicamentos y Productos Sanitarios (AEMPS) — Not provided for this source record
Synchronized
At a glance
- Active ingredient
- CANDESARTAN — 32 mg
- HIDROCLOROTIAZIDA — 25 mg
- Pharmaceutical form Home Med Cabinet grouping
- Tablet
- Availability in Spain
- 1 of 2 packs marketed
Packs
CANDESARTAN/HIDROCLOROTIAZIDA KRKA 32 MG/25 MG COMPRIMIDOS EFG , 28 comprimidos (Blister PVC-PVDC-Aluminio)
28 pcs
National code
Marketed705880Strength of this pack 32 mg
CANDESARTAN/HIDROCLOROTIAZIDA KRKA 32 MG/25 MG COMPRIMIDOS EFG , 28 comprimidos (Blister OPA/Al/PVC/Al)
28 pcs
National code
Not marketed705890Strength of this pack 32 mg
“Marketed” means the authority records the pack as placed on the market. It is not a statement about pharmacy stock.
Official documents
Documents open on the authority’s own site. Home Med Cabinet links to them and hosts no copy.
- Official
Opens on the authority’s own site
- Official
Summary of product characteristics
Opens on the authority’s own site
Registration
- Registration number
- 79669Official data
- Marketing authorisation holder
- KRKA D.D. NOVO MESTOOfficial data
- Authorised
- May 18, 2015Official data
- Authority form code
- 40Official data
Classification
ATC classification is not published here yet
Publication rights for ATC codes and labels are still under review, and no classification is inferred for this record.